The modified model was able to predict more mutations, especially in the lowest decile, as compared with the unmodified BRCApro model.49 Therefore, Rao et al50 established a mutation prediction model based on the characteristics of BRCA1- or BRCA2-associated breast cancers in the Chinese population. This evidence concerns the gene BRCA1 and breast carcinoma.